Following evidence generation that indicates a product has the successful adequacy to treat a medical need, an appropriate regulatory registration procedure is required prior to commercialization.
This entails the definition, execution and formatting of registration eCTD dossiers and their management in terms of timing and content presentation, which are usually subject to standard formats and procedures requested by multiple authority bodies in each regulatory framework. This involves also a contextualization of such procedures regarding the type of product and the medical need to be covered.
Asphalion’s expertise aims at ensuring timely commercialization given the complexity of multiregional contexts, which requires a proper planning and management of document submission and product registration.
Registration Solutions
Schedule a free meeting!
Discuss your case with our experts and receive a valuable feedback
Share
Why Asphalion?
Asphalion has a focused expertise in complying with challenging regulatory requirements, highly tailored for a wide diversity of regional contexts in which multiple agents intervene and allows Asphalion to be a leading partner on the execution, presentation and follow-up of technical regulatory documents, which allows contextualized product registration and maximized efficiency.
At Asphalion we know the requirements that documents must meet in order to be timely approved, especially in dossiers for registration procedures, such as CTD, technical documents for scientific reports or transparency compliance reports.
We cover all aspects, starting from scientific and medical writing, up to support of the registration procedure in compliance with the regulations of each country.
Related Resources
Highlights video
Highlights video
Highlights video
Highlights video
Highlights video
Highlights video
Asphalion contributions to the fight against COVID-19
(CTR) No 536/2014
Asphalion provides comprehensive support during development, certification, registration and post marketing of Medical Devices, IVDs and Combination Products in Europe, US as well as other regions.
At Asphalion, we’re excited to be part of key events, conferences, and summits throughout 2026—great opportunities to connect, exchange insights, and collaborate with leaders across healthcare and medical devices.
DIA Europe 2026 will take place in Rotterdam from 24–26 March 2026. As Europe’s largest neutral conference in the life sciences sector, it will gather 1,500 professionals from over 50 countries for three days of exchange and collaboration. The programme features 10 dynamic tracks covering key areas such as Clinical Trials Innovation, AI & Real-World Evidence, Innovative Therapies, Medical Devices, and Pharmacovigilance, alongside 80+ sessions and contributions from 300+ experts, regulatory authorities, HTA bodies, payers, and patient organizations—offering a key platform to drive innovation and informed decision-making in healthcare.
Meet Our Experts at the 24th RA Conference by Medicines for Europe next week!
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
